When we decided to partner and start a novel consulting firm, we realized that our in depth understanding of Latin America and expertise in the Pharmaceutical and Biotechnology Industry, coupled with our corporate knowledge and proven success record could create a unique alternative for companies seeking real and meaningful advice to their business needs in this region.
That is why we chose the name Electio Consulting. "Electio" is the Latin equivalent of the word 'alternative' and its literal meaning is choice, selection, or option. Thus, Electio Consulting is a "boutique" consulting firm, seeking to become a trusted knowledgeable business partner to its clients.
What makes us different is that we do not come from academia or big consulting firms. We are all former business executives of corporations that were confronted with real business issues and managed them with success. As we say at Electio Consulting: "we've been there, we've done it, and we know the players". Our approach is to bring Solid Advice based through our extensive knowledge, experience and robust network. When providing advisory or management consulting services, different from long and tedious processes, we prefer to provide “to the point” well thought-out Pragmatic Solutions.
Our focus is in the quality of the content, to be fully involved with our client by integrating us as a committed player of their team, bring thoughtful alternatives and support their decision making process and implementation.
In addition, we are very passionate about “Mentoring” leaders in the region to grow to a global level of performance and be highly successful in managing the complexity of today’s challenging Industry and working environment.
Eduardo is an International Senior-level high impact leader and business advisor with deep knowledge and experience running businesses with proven and significant achievements in the Pharmaceutical and Biotechnology industry.
With over 3 decades of experience, Eduardo started his journey in the Pharmaceutical Industry when in 1986 he joined the Glaxo organization in Mexico and had a fast paced ascending career. At age 28 he was promoted to Marketing and Sales Director of the company and 4 years later he was promoted to General Manager of Glaxo Wellcome in Puerto Rico reporting to the President of the Latin American region. There, he led a major turnaround, moving the company from being a small sales unit of the US company to becoming an autonomous, best in class, marketing-driven company. Eduardo built a small, lean and entrepreneurial organization with a modern structure based on technology, outsourcing and partnerships. After the consolidation of GlaxoSmithKline, Eduardo was named Vice President, Marketing Latin America where he provided the commercial vision to the newly merged company, and developed the first combined GSK Strategic Plan.
Eduardo joined Wyeth Pharmaceuticals in 2001 as South America VP and was quickly promoted to Group Vice President Latin America where he took on an organization with long standing stagnant sales and minimal marketing and selling capabilities and transformed it into a focused marketing and sales driven enterprise with a high performance and spirited culture; Through his “1B10” vision, he grew revenues from $400 million/year to over $1.1billion, tripled net profit and significantly improved productivity all across the organization. The Pharmaceutical Latin American division became the fastest growing area for five consecutive years. In 2007 Eduardo was promoted to President of Latin America, reporting to the President of the Pharmaceutical Division, and appointed to the Wyeth Operations Committee, the Pharmaceutical Management Team, and the Global Commercial Team boards.
In May 2010 Eduardo decided to become an entrepreneur by founding Electio Consulting LLC.
In May 2012 in his role as Partner and Founder, Eduardo together with other partners, starts Laboratorios ProGalénika, a small Pharmaceutical and Services Company based in México City. ProGalénika developed a unique business model that facilitates Multinational Pharmaceutical and Biotechnology companies land their presence and products in the country in a timely and cost-effective way.
Eduardo is currently a Senior Advisor of Eunoia Biotech, a preclinical-stage drug delivery company that develops advanced technologies for disease treatment.
Eduardo is also an Executive Mentor to C-Suite executives across a wide range of industries and fucntions.
Eduardo earned his Bachelor's Degree in Business Administration and Finance at Universidad Panamericana in Mexico City, and has had extensive executive education training in finance, communications and leadership at top-tier International business schools.
Eduardo served as Chairman of the PhRMA Latin America Regional Steering Committee from 2006 to 2008 and was a Board Member from 2001 to 2009, and was Chairman and Board Member of the Pharmaceutical Industry Association of Puerto Rico from 1995 to 2000.
Since 2010 Eduardo is a Board Director and former Board President of the non profit organization ACLAMO Family Centers.
Beat is a senior level executive specialized in finance, with a highly successful record of being both an effective business partner and financial controller. He has a refined knowledge of various international business cultures − acquired either on the ground at the local level or through assignments while occupying senior positions at the head office level − and has worked in various business sectors, with emphasis in the pharmaceutical industry.
He was responsible for the finance operations of the Latin America Region of Wyeth Pharmaceuticals, where he led the transformation of a stagnate Region into a high growth/high profit enterprise, drove operational excellence, and changed the focus of the Finance function from accounting to business partnership based. Of particular value is Beat's broad international experience with operational intelligence gained in Japan, Southeast Asia, India, Australia, Mexico, Central and South America, and Europe.
Following Pfizer's acquisition of Wyeth in late 2009, Beat led a team to create the consulting firm, Electio Consulting LLC, where he currently is Executive Partner & Co-Founder. In this latest professional endeavor he has proudly and successfully shared his vast experience by supporting a wide range of US and European based pharmaceutical and biotechnology companies with advisory and consulting services.
The scope of services rendered span from helping a company to fully restructure their operations starting from revamping their long term vision to supporting the buildup of a totally new architecture for a sub-region, to providing comprehensive business analysis and giving advice for the introduction of products in the vaccines, biotechnology and biosimilar markets, to giving advice and providing thorough guidelines for the preparedness of the launch of new highly specialized biotechnology products, to mention just a few of the successful projects Beat was involved in.
Before starting up Electio, Beat was VP Finance & CFO Latin America at Wyeth Pharmaceuticals, where he was the senior finance leader for this $1+ billion sales region, leading its transformation from a $400 million to a $1+ billion operation, tripling operating profit, and quadrupling productivity, all within four years. His prior position at Wyeth was Controller Intercontinental Region where in addition to his day to day Controller responsibilities; he directed finance/accounting coordination between 21 affiliate operations located throughout the Asia/Pacific and Latin America regions.
Beat held earlier roles at Wyeth with increasing responsibility, including Vice President Finance at Wyeth-Ayerst Canada Inc. where he spearheaded the integration of the finance teams resulting from the acquisition of two companies. Prior to this, he held a number of financial management positions at several international companies located in Switzerland, Belgium, Australia, and New Guinea.
Born and educated in Switzerland, Beat graduated with a Baccalaureate in Commerce from Berufs-, Fach- und Fortbildungsschule in Bern, Switzerland, and complemented his formal professional education through a Diploma in Management Information Systems from the McGill University in Montreal, Canada.